Gap Junctions in the Epidermis: Understanding Their Role in Skin Homeostasis and Disease

Role of Gap Junctions in Skin Homeostasis

Gap junctions are crucial for epidermal homeostasis, influencing various aspects of skin biology.

Regulation of Keratinocyte Proliferation and Differentiation: Connexons located at and between keratinocytes regulate the coordinated exchange of signals activating cell proliferation and differentiation to sustain the epidermis turnover. For instance, there is data that Cx43 participation is necessary for the regulation of the orientation of the mitotic spindle during cell division to form new cells in appropriate positions within the epidermal layer.

Maintenance of Epidermal Barrier Function: The epidermal barrier is an organ that shields the body from environmental aggressions, including microbes and water. Connexins are involved in the management of tight junctions and other junctions that are essential to this barrier role. Defects in connexin structure and function, including Connexin 26 and Connexin 43, are disruptive to the barrier and result in inflammation, as seen in eczema and other skin conditions.

Wound Healing and Tissue Repair: Conversely, gap junctions are strategic to restore tissue homeostasis and conduct the communication needed for command of cell migration, enlargement, and differentiation at the wound site. Initially, Cx43 protein levels are known to be downregulated at the wound edge, facilitating keratinocyte migration as well as minimizing inflammation to facilitate rapid wound healing. On the other hand, the constant appearance of Cx43 in chronic ulcers like diabetic foot ulcers has detrimental effects on the healing process due to limitations on cell migration.

Inflammatory Response Modulation: This review also found that the skin’s inflammatory response can be regulated through gap junctions, mainly Cx26 and Cx43. These connexins are claimed to participate in the discharge of signaling molecules such as ATP, which can scale up inflammation signals. Connexin expression has been variously associated with increased inflammation in conditions such as psoriasis, thereby boring features of these diseases.

Dysfunction of Gap Junctions and Skin Diseases

 Mutations of connexin can cause numerous skin diseases, showing how fine-tuned skin conditions must be to be healthy. Some of the notable conditions associated with gap junction dysfunction include:

Psoriasis and Chronic Inflammatory Skin Diseases: Psoriasis involves increased basal keratinocyte proliferation and an augmented inflammatory reaction. Some authors have reported that Cx26 is overexpressed in psoriatic skin lesions and directly contributes to disease pathogenesis by promoting inflammation in the skin and impairing epidermal homeostasis. This overexpression not only impacts the barrier function but also prolongs the chronic inflammation characteristic of psoriasis.

Genetic Skin Disorders: Many genetic skin diseases are associated with mutations in connexin genes, among them GJB2, which codes for connexin 26 (Cx26). For instance, Keratitis-ichthyosis-deafness (KID) syndrome, is also due to mutations that cause abnormal functioning of hemichannels and severe skin reactions along with deafness and keratitis. Such mutations, therefore, lead to a gain of function in which the hemichannels remain constitutively open and cause an adverse cell dysfunction in terms of homeostasis, increased cell death, and inflammation.

Wound Healing Impairments: This review established that connexin expression must be controlled to facilitate proper wound healing. Recently it was published chronic wounds. such as venous ulcers and diabetic foot ulcers have poor prognosis once they overexpress the Cx43. Various congenic mimetic peptides and antisense molecules against Cx43 have been proven effective in increasing the wound closure rates due to the modulation of gap junction communication and decrease in inflammation response for improved healing.

Erythrokeratodermia Variabilis and Other Connexin-Linked Disorders: Erythrokeratodermia variabilis (EKV) is one of the conditions that is linked to mutations in connexins, for instance Cx31. These mutations can lead to skin hyperplasia, scaling, and, at worst, keratoderma. These disorders, in most instances, are related to improper trafficking and function of connexin, which negatively affects cellular signaling and increases the risk of infection and inflammation of the skin.

Therapeutic Approaches Targeting Connexins

Due to the important functions that connexins play in skin physiology and pathophysiology, efforts are underway to design small molecules that selectively target connexin signaling pathways in an attempt to arouse a therapeutic response. Some promising approaches include:

Connexin Mimetic Peptides: These peptides are synthetic molecules that are designed to imitate some parts of connexin proteins and can afford specific blockage of gap junction signaling. For instance, a peptide called Gap27 refutes the Cx43 channels that lead to quicker rates of healing and lesser inflammation in skin models.

Antisense Oligonucleotides: Connexin modulation employing antisense therapy can successfully inhibit gross Connexin expression, for, instance, Connexin 43 in chronic wounds. It has been evidenced that this approach produces effectiveness in acute models, promoting gain in wound healing and a decrease in pathological inflammation.

Gene Therapy and Small Molecule Inhibitors: New approaches are to rescue the mutated connexins by gene or RNA interference or to selectively target the connexin with a specific pharmacotherapeutic agent. These interventions appear promising for the treatment of various skin diseases associated with connexin mutations.

Conclusion

Due to these general characteristics of gap junctions, they are considered to be vital to skin homeostasis, carrying out such basic functions as cell generation, generation of specialized cell descendants, and reaction to harm. It is a key factor that precisely regulation of connexin interactions is critical for maintaining the epidermis integrity and contributing to the proper wound healing process. Nonetheless, when the balance is broken, there occur severe skin pathologies that include but are not limited to genetic skin disorders, chronic wounds, and inflammatory skin conditions. Disruptions of gap junctions in the epidermis are implicated in various skin diseases, and the knowledge of these structures’ functions contributes significantly to the discovery of a disease’s origins as well as potential treatments through the rearrangement of connexin functioning to improve the state of the skin organ.

References

1. Adil, M.S., Narayanan, S.P. and Somanath, P.R., 2021. Cell-cell junctions: structure and regulation in physiology and pathology. Tissue Barriers, 9(1), p.1848212.
2. Asgari, T., Naji, M., Mansouri, P., Mahmoudi, H., Zabihi, M., Youssefian, L., Mahdavi, M., Naraghi, Z.S., Zeinali, S., Vahidnezhad, H. and Uitto, J., 2020. Keratitis‐ichthyosis‐deafness syndrome: phenotypic heterogeneity and treatment perspective of patients with p. Asp50Asn GJB2 mutation. Dermatologic Therapy, 33(6), p.e14493.
3. Beach, R., Abitbol, J.M., Allman, B.L., Esseltine, J.L., Shao, Q. and Laird, D.W., 2020. GJB2 mutations linked to hearing loss exhibit differential trafficking and functional defects as revealed in cochlear-relevant cells. Frontiers in cell and developmental biology, 8, p.215.
4. Cocozzelli, A.G. and White, T.W., 2019. Connexin 43 mutations lead to increased hemichannel functionality in skin disease. International Journal of Molecular Sciences, 20(24), p.6186.
5. Wong, P., Tan, T., Chan, C., Laxton, V., Chan, Y.W.F., Liu, T., Wong, W.T. and Tse, G., 2016. The role of connexins in wound healing and repair: novel therapeutic approaches. Frontiers in physiology, 7, p.596.
6. Chanson, M., Watanabe, M., O’Shaughnessy, E.M., Zoso, A. and Martin, P.E., 2018. Connexin communication compartments and wound repair in epithelial tissue. International journal of molecular sciences, 19(5), p.1354.
7. Valdez Capuccino, J.M., Chatterjee, P., García, I.E., Botello-Smith, W.M., Zhang, H., Harris, A.L., Luo, Y. and Contreras, J.E., 2019. The connexin26 human mutation N14K disrupts cytosolic intersubunit interactions and promotes channel opening. Journal of General Physiology, 151(3), pp.328-341.